Sales started to slow in the spring, as market uncertainty began to weigh on investor confidence, says CEO James O’Sullivan ...

After losing its powerhouse partner, IGM Biosciences closed “most” of its labs and offices and initiated a strategic review ...

Sanofi has scrapped its collaboration with IGM Biosciences, eliminating the biotech’s l | Sanofi has scrapped its ...

Prerna Mathews, Vice President, ETF Product Strategy, Mackenzie Investments ("Mackenzie"), and her team joined Graham MacKenzie, Managing Director, Exchange Traded Products, Toronto Stock Exchange ...

Shares Expanded Tech Sector has seen a significant rebound but remains fairly valued with a mixed technical outlook. Learn ...

Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows.

First Quarter 2025 Results Key Financial Results Revenue: CA$960.9m (up 7.8% from 1Q ...

US biotech IGM Biosciences (Nasdaq: IGMS), which is developing and delivering medicines to treat patients with autoimmune and ...

IGM Financial Inc. reported adjusted net earnings of $237.8 million for the first quarter, up 5.9% from the same quarter of ...

Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows. The new molecule combines the specificity of a mature flu fighter with the ...

IGM Financial Inc (IGIFF) reports record earnings and significant asset growth, while navigating market volatility and strategic challenges.